An Alternative Medicine, Agaricus blazei, May Have Induced Severe Hepatic Dysfunction in Cancer Patients

Eisenberg, 1993, Unconventional medicine in the United States. Prevalence, costs, and patterns of use, N Engl J Med, 328, 246, 10.1056/NEJM199301283280406

Fernandez, 1998, Alternative and complementary therapy use in pediatric oncology patients in British Columbia: prevalence and reasons for use and nonuse, J Clin Oncol, 16, 1279, 10.1200/JCO.1998.16.4.1279

Eisenberg, 1998, Trends in alternative medicine use in the United States, 1990–1997: results of a follow-up national survey, JAMA, 280, 1569, 10.1001/jama.280.18.1569

Pratt, 2000, Evaluation of abnormal liver-enzyme results in asymptomatic patients, N Engl J Med, 342, 1266, 10.1056/NEJM200004273421707

Durant, 1998, Alternative medicine: an attractive nuisance, J Clin Oncol, 16, 1, 10.1200/JCO.1998.16.1.1

Labriola, 1999, Possible interactions between dietary antioxidants and chemotherapy, Oncology (Williston Park), 13, 1003

Faggioli, 1997, Acute hepatic toxicity during cyclic chemotherapy in non Hodgkin's lymphoma, Haematologica, 82, 38

Sato, 1997, Acute exacerbation of hepatitis due to reactivation of hepatitis B virus with mutations in the core region after chemotherapy for malignant lymphoma, J Gastroenterol, 32, 668, 10.1007/BF02934119

Cassileth, 1999, Complementary and alternative cancer medicine, J Clin Oncol, 17, 44

DiPaola, 1998, Clinical and biologic activity of an estrogenic herbal combination (PC-SPES) in prostate cancer, N Engl J Med, 339, 785, 10.1056/NEJM199809173391201

Lerner, 1992, The prevalence of questionable methods of cancer treatment in the United States, CA Cancer J Clin, 42, 181, 10.3322/canjclin.42.3.181

Metz, 2001, Cancer patients use unconventional medical therapies far more frequently than standard history and physical examination suggest, Cancer J, 7, 149

Cassileth, 1984, Contemporary unorthodox treatments in cancer medicine. A study of patients, treatments, and practitioners, Ann Intern Med, 101, 105, 10.7326/0003-4819-101-1-105

Miller, 1998, Phase I/II trial of the safety and efficacy of shark cartilage in the treatment of advanced cancer, J Clin Oncol, 16, 3649, 10.1200/JCO.1998.16.11.3649